CELLIVERY

ABOUT US

PARTNERSHIP & COLLABORATION

CMOs

  • Richter-Helm (Hamburg, Germany)

    Area of Collaboration: Process Development and Manufacturing of iCP-SOCS3

  • KBI Biopharma (Durham, North Carolina, USA)

    Area of Collaboration: Cell Line Development and Manufacturing of iCP-Parkin

  • Catalent (Beinheim, France)

    Area of Collaboration: Encapsulation Process Development of iCP-NI

  • Eurofins (Ghent, Belgium)

    Area of Collaboration: Cream Formulation Development of iCP-NI

  • Aldevron (Madison, Wisconsin, USA)

    Area of Collaboration: Process Development and Manufacturing of CP-BMP2

CROs

  • Charles River (Kuopio, Finland)

    Area of Collaboration: Efficacy study of iCP-Parkin

  • Atuka (Toronto, Canada)

    Area of Collaboration: Efficacy study of iCP-Parkin

  • Integrity Bio (CA, US)

    Area of Collaboration: Formulation study of iCP-Parkin & iCP-SOCS3 Drug Product (DP) manufacturing for iCP-NI

  • Covance (Huntingdon, UK, Somerset, US, New Jersey, US)

    Area of Collaboration: Safety study and analytical method development of iCP-Parkin Toxicity study for iCP-NI Regulatory (Pre-IND & IND) consulting for iCP-NI

  • KBI (Kunming, China)

    Area of Collaboration: Monkey Safety/Toxicity study of iCP-SOCS3